![Peter Chambré](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Chambré
Président chez
IMMATICS N.V.
Fortune : 1 M $ au 31/05/2026
Profil
Peter Alan Chambré is Chairman at Cancer Research Technology Ltd. since 2011, Chairman at Immatics US, Inc. since 2012, Chairman at Immatics NV since 2021, Chairman at 7tm Holding ApS, Trustee at Cancer Research UK since 2016, and Trustee at Our Future Health Uk.
Former roles include Chief Executive Officer at MedImmune Ltd. from 2002 to 2006, Chief Executive Officer at Consort Medical Ltd., Chief Executive Officer at Cambridge Antibody Technology Group Ltd. from 2002 to 2006, Chairman at ApaTech Ltd. from 2008 to 2010, Chairman at Immatics Biotechnologies GmbH from 2012 to 2020, Chairman at Xellia Pharmaceuticals AS from 2008 to 2013, Chairman at Asker Healthcare Holding AB from 2011 to 2019, Chairman at 7TM A, Independent Non-Executive Director at Touchstone Innovations Ltd. from 2014 to 2017, Independent Non-Executive Director at UDG Healthcare Ltd. (Dublin), Independent Non-Executive Director at BTG Ltd. from 2006 to 2012, Independent Non-Executive Director at Spectris Ltd. from 2006 to 2016, Advisor at 3i Group Plc, Principal at Unilever Plc, Principal at Bain & Co., Inc., Chief Operating Officer at Celera Group, and Trustee at Cancer Research UK.
Education includes undergraduate studies at The University of Reading.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IMMATICS N.V. 0,08 % | 18/03/2026 | 105 987 ( 0,08 % ) | 1 M $ | 31/05/2026 |
Postes actifs de Peter Chambré
| Sociétés | Poste | Début |
|---|---|---|
| IMMATICS N.V. | Président | 01/10/2012 |
Cancer Research Technology Ltd.
 Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Develops cancer therapeutics, vaccines, and diagnostics | Président | 01/10/2011 |
Our Future Health Uk
 Our Future Health Uk Miscellaneous Commercial ServicesCommercial Services Provides support services | Directeur/Membre du Conseil | - |
7tm Holding ApS | Président | - |
Immatics US, Inc.
 Immatics US, Inc. BiotechnologyHealth Technology Develops adoptive cell therapies for treatment of cancer | Président | 01/11/2012 |
Cancer Research UK
 Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Provides cancer research services | Directeur/Membre du Conseil | 01/01/2016 |
Anciens postes connus de Peter Chambré
| Sociétés | Poste | Fin |
|---|---|---|
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Président | 01/01/2020 |
OneMed AB
 OneMed AB Medical DistributorsDistribution Services Distributes medical supplies and provides consulting, process optimization and tools | Président | 01/01/2019 |
| TOUCHSTONE INNOVATIONS PLC | Directeur/Membre du Conseil | 31/01/2017 |
| ░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Peter Chambré
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
73
Relations au 1er degré
23
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 23 |
|---|---|
3i Group Plc
 3i Group Plc Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
Unilever Plc
 Unilever Plc Household/Personal CareConsumer Non-Durables Provides fast moving consumer goods | Consumer Non-Durables |
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology Engages in research and development of human monoclonal antibodies | Health Technology |
Consort Medical Ltd.
 Consort Medical Ltd. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Touchstone Innovations Ltd.
 Touchstone Innovations Ltd. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Spectris Plc
 Spectris Plc Electronic Equipment/InstrumentsElectronic Technology Develops and supplies precision measurement equipment and software | Electronic Technology |
BTG Ltd.
 BTG Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies drugs used in the treatment of neurological disorders | Health Technology |
UDG Healthcare Ltd. (Dublin)
 UDG Healthcare Ltd. (Dublin) Miscellaneous Commercial ServicesCommercial Services Provides healthcare advisory, communications, commercial, clinical and packaging services | Commercial Services |
Bain & Co., Inc.
 Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Provides strategy, marketing, organization, operations, IT and M&A consulting services | Commercial Services |
Celera Group
 Celera Group Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for cancer, autoimmune and inflammatory diseases | Health Technology |
The University of Reading
 The University of Reading Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ApaTech Ltd.
 ApaTech Ltd. Medical SpecialtiesHealth Technology Provides bone graft technologies | Health Technology |
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Health Technology |
Cancer Research Technology Ltd.
Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Develops cancer therapeutics, vaccines, and diagnostics | Health Technology |
7TM A/S
 7TM A/S BiotechnologyHealth Technology Operates as a biotech company that discovers and develops drugs | Health Technology |
Cancer Research UK
Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Provides cancer research services | Commercial Services |
Xellia Pharmaceuticals AS
 Xellia Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies pharmaceutical drugs | Health Technology |
OneMed AB
OneMed AB Medical DistributorsDistribution Services Distributes medical supplies and provides consulting, process optimization and tools | Distribution Services |
Immatics US, Inc.
Immatics US, Inc. BiotechnologyHealth Technology Develops adoptive cell therapies for treatment of cancer | Health Technology |
Cambridge Antibody Technology Group Ltd.
 Cambridge Antibody Technology Group Ltd. Miscellaneous Commercial ServicesCommercial Services Functions as an holding company whose subsidiaries researches, develops and exploits molecular engineering products | Commercial Services |
Immatics NV
 Immatics NV Pharmaceuticals: MajorHealth Technology Engages in developing immunotherapies for cancer treatments | Health Technology |
7tm Holding ApS | |
Our Future Health Uk
Our Future Health Uk Miscellaneous Commercial ServicesCommercial Services Provides support services | Commercial Services |
